Company intelligence / Profile preview

Blueshift Biotechnologies

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

Blueshift Biotechnologies was a life sciences instrumentation company specializing in high-content screening and cell-based analysis. The company developed the IsoCyte laser scanning imager, which provided high-speed, high-resolution imaging for drug discovery and development. Its technology enabled researchers to perform rapid, automated analysis of cellular assays in microplate formats. Blueshift's products were designed to bridge the gap between primary screening and detailed cellular analysis. The company was acquired by Molecular Devices in 2008 to enhance its imaging and analysis portfolio.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Blueshift Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blueshift Biotechnologies.

Explore the full profile